Crossmark

Comparison of efficacy of rifaximin, probiotics and l-ornithine l-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-025-09173-2

Published Online: 2025-11-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shahbaz, Amna

Jamil, QurratulAin

Iqbal, Shahid Muhammad

Jamil, Muhammad Nauman

Khan, Jawad Akbar

Aufy, Mohammed
Funding

Funding for this research was provided by:

University of Vienna
License Information

Text and Data Mining valid from 2025-11-21

Version of Record valid from 2025-11-21
More Information

Article History

Received: 24 March 2025

Accepted: 27 September 2025

First Online: 21 November 2025

Declarations

:

: This study protocol is approved by the Pharmacy Human Ethics Committee (PHEC) of the Islamia University of Bahawalpur (187–2023-/PHEC).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below